Photo of Ketan Badani

Ketan Badani

Print ProfilePrint Profile



  • American Board of Urology


  • MD, Case Western Reserve University

  • Residency, Urology
    Henry Ford Health Systems

  • Fellowship, Robotic Urology
    Henry Ford Health Systems


    Dr. Ketan K. Badani is Professor of Urology, Icahn School of Medicine at Mount Sinai, Vice Chairman of Urology and Robotic Operations at Mount Sinai Health System, Director of Robotic Surgery at Mount Sinai, St. Luke’s, and Roosevelt Hospitals, and the Director of the Comprehensive Kidney Cancer Program At Mount Sinai Health System.

    Dr. Badani is recognized as a world leader in the research and treatment of urologic oncology.  Specifically, he has focused his work on prostate and kidney cancer.  Dr. Badani has led teams that first developed and published techniques for minimally invasive robotic kidney cancer surgery.  His technique of robotic partial nephrectomy, The “F.A.S.T.” procedure has been published and taught around the world to treat patients with renal tumors.  Dr. Badani leads a team seeking to improve treatment of these cancers by finding less invasive and effective therapy, while maintaining quality of life factors after surgery. 

    Dr. Badani has performed nearly 4,000 robotic procedures in his career, placing him in the top 1% of urologists worldwide. He is one the preeminent practitioners in the world for robotic partial nephrectomy for complex kidney tumors, and robotic prostatectomy for localized prostate cancer; he has the largest combined experience in robotic kidney and prostate cancer in the New York area.  Dr. Badani’s clinical expertise spans both surgical and non-surgical approaches to treatment of urologic cancers.  He has just completed one of the largest decision impact studies evaluating genomic biomarkers for active surveillance in men with low risk prostate cancer.

    As Visiting Professor, Dr. Badani has given lectures and demonstrated surgery in over 20 countries.  Most recently he visited prominent institutions in the United States, Canada, Brazil, Japan, India, Malaysia, Venezuela, China, Spain, and Turkey to teach his technique.  He is the author of over 150 peer-reviewed publications and has presented over 200 abstracts at national and international meetings.  He has led the prostate and kidney cancer research program at Columbia University Medical Center for the past 7 years.  Dr. Badani is involved in numerous clinical trials, feasibility and safety studies of new technology, and health related quality of life outcomes research.   He serves as an editor and/or reviewer for numerous publications including Cancer, Journal of Urology, Urologic Oncology, Journal of Endourology, among others.

    As Director of the Comprehensive Kidney Cancer Program at Mount Sinai Heath System, Dr. Badani will develop a multispecialty clinical program for kidney cancer patients that will span the treatment spectrum including surgery, nephrology, interventional radiology, and complementary medicine.  Clinically, the program will allow individualized care to each patient with kidney cancer based on the tumor stage, grade, and overall health.  Academically, the program will be on the cutting edge for innovative technology based research, and latest clinical trials.

    Dr. Badani graduated in the top of his class from Case Western Reserve University School of Medicine in Cleveland, Ohio.  He went on to complete his urology residency at the world renowned Vattikuti Urology Institute at Henry Ford Hospital in Detroit, MI (his hometown).  He also completed a fellowship in minimally invasive urologic oncology at the Vattikuti Urology Institute, where robotic urologic surgery was first performed in the United States.  Upon completion of his training, Dr. Badani joined the faculty at Columbia University Medical Center.

    Dr. Badani will see patients at two locations: Mount Sinai Hospital (5 East 98th Street) and Mount Sinai Roosevelt (425 West 59th Street).  His office can be contacted by calling (212)241-3919.  He can be reached via email at


  • 2013 -
    Best research poster
    AUA Annual Meeting

  • 2013 -
    Honorary Editorial Board Member
    Robotic Surgery Research and Reviews

  • 2013 -
    Rising Star Award

  • 2013 - 2015
    Top Doctor
    Castle Connolly

  • 2012 -
    Best of ther Best - Video - honorable Mention
    AUA Annual Meeting

  • 2011 -
    Outstanding Contribution Award
    International Prostate Cancer Symposium

  • 2010 -
    Nominee Surgeon of the Year
    New York Presbyterian Hospital

  • 2010 - 2011
    America;s Top Urologists
    Consumers Research Council of America

  • 2010 - 2011
    America's top Surgeons
    Consumers Research Council of America



Korets R, Weinberg AC, Alberts BD, Woldu SL, Mann MJ, Badani KK. Utilization and Timing of Blood Transfusions Following Open and Robot Assisted Radical Prostatectomy. Journal of endourology / Endourological Society 2014 Aug;.

Weinberg AC, Woldu SL, Bergman A, Roychoudhury A, Patel T, Berg W, Wambi C, Badani KK. Dorsal penile nerve block for robot-assisted radical prostatectomy catheter related pain: a randomized, double-blind, placebo-controlled trial. SpringerPlus 2014; 3.

Badani KK, Thompson DJ, Brown G, Holmes D, Kella N, Albala D, Singh A, Buerki C, Davicioni E, Hornberger J. Effect of a genomic classifier test on clinical practice decisions for patients with high-risk prostate cancer after surgery. BJU international 2014 Apr;.

Berg WT, Shapiro EY, Rothberg MB, Bergman A, Scarberry K, Wambi C, Patel T, Badani KK. Baseline Serum 25-Hydroxyvitamin D Levels in Men Undergoing Radical Prostatectomy: Is There An Association With Adverse Pathologic Features?. Clinical genitourinary cancer 2014 Feb;.

Woldu SL, Weinberg AC, Bergman A, Shapiro EY, Korets R, Motamedinia P, Badani KK. Pain and analgesic use after robot-assisted radical prostatectomy. Journal of endourology / Endourological Society 2014 May; 28(5).

Woldu SL, Patel T, Shapiro EY, Bergman AM, Badani KK. Outcomes with delayed dorsal vein complex ligation during robotic assisted laparoscopic prostatectomy. The Canadian journal of urology 2013 Dec; 20(6).

Al-Daghmin A, Kauffman EC, Shi Y, Badani K, Balbay MD, Canda E, Dasgupta P, Ghavamian R, Grubb R, Hemal A, Kaouk J, Kibel AS, Maatman T, Menon M, Mottrie A, Nepple K, Pattaras JG, Peabody JO, Poulakis V, Pruthi R, Palou Redorta J, Rha KH, Richstone L, Schanne F, Scherr DS, Siemer S, Stöckle M, Wallen EM, Weizer A, Wiklund P, Wilson T, Wilding G, Woods M, Guru KA. Efficacy of robot-assisted radical cystectomy (RARC) in advanced bladder cancer: results from the International Radical Cystectomy Consortium (IRCC). BJU international 2014 Jul; 114(1).

Ahmed K, Khan SA, Hayn MH, Agarwal PK, Badani KK, Balbay MD, Castle EP, Dasgupta P, Ghavamian R, Guru KA, Hemal AK, Hollenbeck BK, Kibel AS, Menon M, Mottrie A, Nepple K, Pattaras JG, Peabody JO, Poulakis V, Pruthi RS, Redorta JP, Rha KH, Richstone L, Saar M, Scherr DS, Siemer S, Stoeckle M, Wallen EM, Weizer AZ, Wiklund P, Wilson T, Woods M, Khan MS. Analysis of intracorporeal compared with extracorporeal urinary diversion after robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. European urology 2014 Feb; 65(2).

Pollard ME, Levinson AW, Shapiro EY, Cha DY, Small AC, Mohamed NE, Badani KK, Gupta M. Comparison of 3 upper tract anticarcinogenic agent delivery techniques in an ex vivo porcine model. Urology 2013 Dec; 82(6).

Patel T, Wambi C, Berg WT, Bergman A, Shapiro EY, Badani KK. Characterization of perioperative leukocytosis in patients undergoing robot-assisted radical prostatectomy: effects of Gleason score and race. Journal of endourology / Endourological Society 2013 Dec; 27(12).

Patel T, Wambi CC, Berg W, Inusa MD, Menon M, Badani K. Prostate cancer disease characteristics for foreign-born South Asian men living in the United States. Indian journal of cancer; 50(3).

Shapiro EY, Scarberry K, Patel T, Bergman A, Ahn JJ, Sahi N, RoyChoudhury A, Deutch I, McKiernan JM, Benson MC, Badani KK. Comparison of robot-assisted and open retropubic radical prostatectomy for risk of biochemical progression in men with positive surgical margins. Journal of endourology / Endourological Society 2014 Feb; 28(2).

Patel T, Wambi C, Berg WT, Bergman A, Shapiro EY, Badani KK. Characterization of Perioperative Leukocytosis in Patients undergoing Robotic assisted Retropubic Prostatectomy: Effects of Gleason score and Race. Journal of endourology / Endourological Society 2013 Sep;.

Badani KK, Shapiro EY, Berg WT, Kaufman S, Bergman A, Wambi C, Roychoudhury A, Patel T. A Pilot Study of Laparoscopic Doppler Ultrasound Probe to Map Arterial Vascular Flow within the Neurovascular Bundle during Robot-Assisted Radical Prostatectomy. Prostate cancer 2013; 2013.

Borregales LD, Berg WT, Tal O, Wambi C, Kaufman S, Gaya JM, Urzúa C, Badani KK. 'Trifecta' after radical prostatectomy: is there a standard definition?. BJU international 2013 Jul; 112(1).

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Badani did not report having any of the following types of financial relationships with industry during 2015 and/or 2016: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Insurance Information

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Edit profile in Sinai Central


Faculty Practice Associates Floor 6
5 East 98th Street
New York, NY 10029

Tel: 212-241-3919


425 West 59th Street
4th Floor
New York, NY 10019


Icahn (East) Building Floor 6 Room 51
1425 Madison Avenue
New York, NY 10029

New Office

5 East 98th Street
New York, NY 10029

Tel: 212-241-3919
Get Directions

Office Hours:
  • Wednesday 1:00am - 4:30pm
  • Friday 1:00am - 4:30pm

New Office

425 West 59th Street
New York, NY 10025

Tel: 212-241-3919
Get Directions

Office Hours:
  • Tuesday 9:00am - 4:30pm